Generic pipeline of products is yet again a smart strategy.
Allows revenue regardless of how large to trickle in providing effective cash flow that can be used to streamline patented products they are wanting to get through the FDA process.
This is one major win for the 3 year plan with this equity.
Very very interesting to see where this stock ends up in the next 12-24 months
- Forums
- ASX - By Stock
- Ann: Acrux Receives FDA Approval - Generic Testosterone Solution
ACR
acrux limited
Add to My Watchlist
5.00%
!
1.9¢

Generic pipeline of products is yet again a smart...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $7.747M |
Open | High | Low | Value | Volume |
2.0¢ | 2.0¢ | 1.9¢ | $13.72K | 687.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 618035 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 618035 | 0.019 |
3 | 381800 | 0.018 |
3 | 472000 | 0.017 |
1 | 66732 | 0.015 |
1 | 70000 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 10000 | 1 |
0.021 | 177000 | 1 |
0.022 | 27574 | 2 |
0.023 | 115126 | 4 |
0.024 | 306848 | 8 |
Last trade - 14.19pm 18/06/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
The Watchlist
CDE
CODEIFAI LIMITED
John Houston / Martin Ross, Executive Chairman / COO
John Houston / Martin Ross
Executive Chairman / COO
Previous Video
Next Video
SPONSORED BY The Market Online